查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2160858

新食品市場預測至2034年—按類型、配料、應用、形態、最終用戶和地區分類的全球分析

Novel Food Market Forecasts to 2034 - Global Analysis By Type (Plant-Based Alternatives, Insect-Based Food, Microbial & Algae-Based Food, Cultured & Lab-Grown Meat and Novel Plant Extracts), Source, Application, Form, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球新奇食品市場規模將達到 45 億美元，並在預測期內以 16.4% 的複合年成長率成長，到 2034 年將達到 152 億美元。

新型食品是指在監管參考日期之前人類尚未大量食用過的創新食品和配料，包括培養肉、昆蟲蛋白和微生物營養素。這些食品利用先進的生物技術、微發酵和細胞農業，為傳統農業提供了永續且高效的營養替代方案。這些產品包括植物來源替代食品、昆蟲衍生食品和實驗室培育肉類，最大限度地減少了對環境的影響。使用這些產品可以確保糧食安全，減少土地和水資源的消耗，並支持世界向永續飲食模式轉型，造福子孫後代。

迫切需要替代蛋白質來源

隨著全球人口成長和對替代蛋白質來源的迫切需求，食品生產商被迫採用創新食品解決方案，以提供永續且高效的營養替代方案。人們對傳統畜牧業環境限制的認知不斷提高，正在加速這些創新產品融入主流飲食。細胞農業的進步為這一轉變提供了支持，提高了生產的擴充性和成本效益。因此，食品品牌正在投資專門的新型食品技術，以在滿足嚴格的永續性標準的同時，最佳化全球糧食安全的成本。

嚴格的法規核准流程

核准新食品的監管流程複雜，嚴重阻礙了其商業性化應用。開發安全且標準化的新食品配料通常需要複雜的毒性測試和先進的品管技術，這導致整體開發成本增加，上市時間延長。此外，各地食品安全法規的差異也限制了標準化新食品產品線的規模化。這些因素共同阻礙了市場擴張，尤其對於合規和法律預算有限的中小型企業而言更是如此。

培養肉和微發酵領域的拓展

由於消費者對符合倫理且資源節約的動物產品的需求日益成長，培養肉和微發酵領域為新興食品供應商提供了巨大的發展機會。先進的生物反應器技術以細胞增殖為主要原料，無需屠宰動物即可有效生產真正的肉類和乳蛋白質。隨著全球對食品生物技術投資的不斷成長，以及監管機構對環境友善蛋白質生產方法的支持，先進的人造肉和發酵產品的應用預計將顯著增加。

消費者的懷疑和“厭惡”

消費者對新食品調查方法的持續質疑對新食品市場構成重大威脅。傳統的、以天然食品為中心的飲食方式和成熟的有機農業系統往往享有較高的消費者信任度，且更適合大規模生產，經濟效益也更高。此外，傳統永續農業的快速發展提高了傳統食品生產方式的效率。這種競爭會阻礙新食品的市場滲透，尤其是在消費者即時接受新食品以及文化飲食習慣是企業營運的關鍵考量因素時。

新型冠狀病毒（COVID-19）的影響：

疫情初期，由於物流限制及外食需求下降，新型食品的供應鏈受到衝擊，生物反應器的安裝也因此延緩。然而，人們對通用感染疾病的認知不斷提高，以及對食品安全的擔憂日益加劇，隨後加速了新型食品技術在高效蛋白質生產方面的應用。疫情後，人們對疫情防範和永續農業的重視，加強了對新型食品技術的長期投資，推動了全球各食品領域的強勁市場復甦與擴張。

在預測期內，植物來源替代食品領域預計將佔據最大的市場佔有率。

由於植物來源替代食品市場成熟度極高，且廣泛適用於各種不同的飲食環境，預計在預測期內，該細分市場將佔據最大的市場佔有率。植物來源替代品具有卓越的質地可複製性，並且可以透過主流零售管道有效推廣，從而顯著降低消費者接受度，並最大限度地減少日常食品消費對環境的影響。隨著業界越來越重視擴充性且經濟高效的肉類和乳製品替代方案，對特色植物來源替代品的需求持續激增，鞏固了其市場主導地位。

預計在預測期內，培養肉和實驗室培育肉細分市場將呈現最高的複合年成長率。

在預測期內，受生物反應器工程和細胞增殖技術的快速發展所推動，培養肉和實驗室培育肉類領域預計將呈現最高的成長率。這些技術能夠精確複煞車物肌肉組織，生產出高度專業且性能穩定的肉品，以滿足特定的烹飪需求。先進的細胞整合技術顯著提高了產量、運作穩定性和環境法規合規性，從而顯著提升了生產過程的經濟效益。因此，對食品生物技術的投資增加以及有利的法規結構正在加速全球商業性應用。

市佔率最大的地區：

在預測期內，歐洲地區預計將佔據最大的市場佔有率，這得益於其完善的食品安全體系和積極利用新型食品的先進生物技術產業。該地區受益於大量的研發投入、健全的智慧財產權保護以及政府對永續農業和食品創新的支持。此外，英國和瑞士等主要產業參與者率先採納了先進的新型食品法規，進一步鞏固了該地區的全球主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於新興經濟體的快速都市化以及各國為保障糧食安全所做的努力。中國、日本和新加坡等國正在加大對細胞農業基礎設施和新型食品製造技術的投資，以滿足國內日益成長的蛋白質需求和日益嚴格的環境法規。此外，有利的政府政策、不斷成長的外國直接投資以及經濟高效的生物技術資源的可用性，正在加速全部區域新型食品的普及應用。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

目錄

第1章：執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球新食品市場：按類型分類

  • 植物來源的替代品
  • 昆蟲衍生食品
  • 源自微生物和藻類的食品
  • 培養肉和實驗室培育肉
  • 新型植物萃取物

第6章：全球新興食品市場：依來源分類

  • 植物
  • 動物源性
  • 微生物來源
  • 真菌和藻類
  • 合成/實驗室衍生

第7章：全球新興食品市場：按應用

  • 乳製品替代品
  • 肉類替代品
  • 麵包糖果甜點
  • 飲料
  • 膳食補充品和營養保健品
  • 嬰兒配方奶粉

第8章：全球新興食品市場：依形式分類

  • 固體的
  • 液體
  • 粉末
  • 凝膠

第9章：全球新興食品市場：依最終用戶分類

  • 食品和飲料製造商
  • 製藥公司
  • 營養保健品公司
  • 動物飼料業

第10章 全球新興食品市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Impossible Foods
  • Beyond Meat
  • Eat Just, Inc.
  • Upside Foods（formerly Memphis Meats）
  • Mosa Meat
  • Solar Foods
  • Air Protein
  • Ynsect
  • Protix
  • The EVERY Company（formerly Clara Foods）
  • Perfect Day
  • Nature's Fynd
  • Meati Foods
  • MycoTechnology, Inc.
  • Shiok Meats
  • Avant Meats
  • Entomo Farms
  • Ginkgo Bioworks
Product Code: SMRC40318

According to Stratistics MRC, the Global Novel Food Market is accounted for $4.5 billion in 2026 and is expected to reach $15.2 billion by 2034 growing at a CAGR of 16.4% during the forecast period. Novel food refers to innovative food products and ingredients that have not been significantly consumed by humans prior to regulatory baseline dates, encompassing cultured meats, insect proteins, and microbial-derived nutrients. They function by utilizing advanced biotechnology, precision fermentation, and cellular agriculture to provide sustainable, high-efficiency nutritional alternatives to traditional farming. These products include plant-based alternatives, insect-based foods, and lab-grown meats that ensure minimal environmental impact. Their application ensures food security, reduces land and water usage, and supports the global transition toward next-generation sustainable diets.

Market Dynamics:

Driver:

Urgent Need for Alternative Protein Sources

The escalating global population and urgent need for alternative protein sources compel food manufacturers to adopt novel food solutions offering sustainable and efficient nutritional alternatives. Growing recognition of the environmental limitations of traditional livestock farming is accelerating the integration of these innovative products into mainstream dietary frameworks. This transition is supported by advancements in cellular agriculture, which enhance production scalability and cost-efficiency. Consequently, food brands are investing in specialized novel food technologies to achieve compliance with stringent sustainability benchmarks while optimizing global food security costs.

Restraint:

Stringent Regulatory Approval Processes

The substantial regulatory complexities associated with approving novel food products represent a significant barrier to widespread commercial adoption. Developing highly safe and standardized novel ingredients often requires complex toxicological testing and sophisticated quality control techniques, which escalate overall development costs and time-to-market. Furthermore, the variability in regional food safety regulations limits the operational scalability of standardized novel food pipelines. These factors collectively constrain market expansion, particularly for smaller enterprises with limited compliance and legal budgets.

Opportunity:

Expansion in Cultured Meat and Precision Fermentation

The cultured meat and precision fermentation sector presents substantial growth opportunities for novel food providers due to increasing demand for ethical and resource-efficient animal products. Advanced bioreactor technologies offer a highly effective pathway to produce real meat and dairy proteins without animal slaughter, utilizing cellular replication as primary inputs. As global investments in food biotechnology expand and regulatory agencies favor low-impact protein pathways, the adoption of advanced cultured and fermented products is expected to surge significantly.

Threat:

Consumer Skepticism and the "Yuck Factor"

The continuous consumer skepticism regarding novel food methodologies poses a considerable threat to the novel food market. Traditional whole-food diets and established organic farming frameworks often exhibit superior consumer trust and can be more economically viable for mass-market food production. Additionally, the rapid advancement of conventional sustainable agriculture is enhancing the efficiency of traditional food methods. This competitive pressure may hinder market penetration, particularly where immediate consumer acceptance and cultural dietary habits are primary operational considerations.

Covid-19 Impact:

The pandemic initially disrupted novel food supply chains and delayed bioreactor installations due to logistical constraints and reduced food service demand. However, the subsequent surge in zoonotic disease awareness and food security concerns accelerated the adoption of novel food technologies for resilient protein production. Post-pandemic, the heightened focus on pandemic preparedness and sustainable agriculture has reinforced long-term investments in novel food technologies, driving robust market recovery and expansion across diverse food sectors globally.

The plant-based alternatives segment is expected to be the largest during the forecast period

The plant-based alternatives segment is expected to account for the largest market share during the forecast period, due to its unparalleled market maturity and widespread applicability across diverse dietary environments. Plant-based alternatives offer exceptional sensory replication and operate effectively in mainstream retail channels, which significantly reduces consumer adoption barriers and minimizes environmental impact in daily food consumption. As industries increasingly prioritize scalable and cost-effective meat and dairy replacement methods, the demand for specialized plant-based alternatives continues to surge, thereby solidifying its dominant market position.

The cultured & lab-grown meat segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cultured & lab-grown meat segment is predicted to witness the highest growth rate, driven by rapid advancements in bioreactor engineering and cellular proliferation techniques. These technologies enable the precise replication of animal muscle tissue to produce highly specialized and robust meat outputs tailored for specific culinary applications. The ability to enhance production yield, operational stability, and environmental compliance through advanced cellular integration significantly improves process economics. Consequently, increasing investments in food biotechnology and favorable regulatory frameworks are accelerating commercial adoption globally.

Region with largest share:

During the forecast period, the Europe region is expected to hold the largest market share, due to the presence of well-established food safety frameworks and advanced biotechnology industries that heavily utilize novel food products. The region benefits from substantial research and development investments, robust intellectual property protection, and supportive government initiatives promoting sustainable agriculture and dietary innovation. Furthermore, the early adoption of advanced novel food regulations by key industry players in the United Kingdom and Switzerland reinforces the region's dominant position globally.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapid urbanization and expanding food security initiatives in emerging economies. Countries such as China, Japan, and Singapore are increasingly investing in cellular agriculture infrastructure and novel food manufacturing technologies to meet growing domestic protein demands and stringent environmental regulations. Additionally, favorable government policies, rising foreign direct investment, and the availability of cost-effective biotechnological resources are collectively driving the accelerated adoption of novel food across the region

Key players in the market

Some of the key players in Novel Food Market include Impossible Foods, Beyond Meat, Eat Just, Inc., Upside Foods (formerly Memphis Meats), Mosa Meat, Solar Foods, Air Protein, Ynsect, Protix, The EVERY Company (formerly Clara Foods), Perfect Day, Nature's Fynd, Meati Foods, MycoTechnology, Inc., Shiok Meats, Avant Meats, Entomo Farms, and Ginkgo Bioworks.

Key Developments:

In September 2026, Upside Foods launched a next-generation cultured chicken product optimized for commercial food service, achieving a thirty percent improvement in cellular growth rate while significantly reducing bioreactor energy requirements for global food manufacturers.

In August 2026, Impossible Foods expanded its plant-based heme production capacity through a strategic partnership with a leading fermentation firm, enabling the scalable deployment of novel flavor-enhancing modules for sustainable meat synthesis.

In July 2026, Mosa Meat secured a major supply agreement to provide customized cultured beef patties for a prominent European retail chain, facilitating the efficient integration of advanced cellular agriculture tools into next-generation grocery ecosystems globally.

Types Covered:

  • Plant-Based Alternatives
  • Insect-Based Food
  • Microbial & Algae-Based Food
  • Cultured & Lab-Grown Meat
  • Novel Plant Extracts

Sources Covered:

  • Plant
  • Animal
  • Microbial
  • Fungi & Algae
  • Synthetic/Lab

Applications Covered:

  • Dairy Alternatives
  • Meat Alternatives
  • Bakery & Confectionery
  • Beverages
  • Supplements & Nutraceuticals
  • Infant Formula

Forms Covered:

  • Solid
  • Liquid
  • Powder
  • Gel

End Users Covered:

  • Food & Beverage Manufacturers
  • Pharmaceutical Companies
  • Nutraceutical Companies
  • Animal Feed Industry

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Novel Food Market, By Type

  • 5.1 Plant-Based Alternatives
  • 5.2 Insect-Based Food
  • 5.3 Microbial & Algae-Based Food
  • 5.4 Cultured & Lab-Grown Meat
  • 5.5 Novel Plant Extracts

6 Global Novel Food Market, By Source

  • 6.1 Plant
  • 6.2 Animal
  • 6.3 Microbial
  • 6.4 Fungi & Algae
  • 6.5 Synthetic/Lab

7 Global Novel Food Market, By Application

  • 7.1 Dairy Alternatives
  • 7.2 Meat Alternatives
  • 7.3 Bakery & Confectionery
  • 7.4 Beverages
  • 7.5 Supplements & Nutraceuticals
  • 7.6 Infant Formula

8 Global Novel Food Market, By Form

  • 8.1 Solid
  • 8.2 Liquid
  • 8.3 Powder
  • 8.4 Gel

9 Global Novel Food Market, By End User

  • 9.1 Food & Beverage Manufacturers
  • 9.2 Pharmaceutical Companies
  • 9.3 Nutraceutical Companies
  • 9.4 Animal Feed Industry

10 Global Novel Food Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiling

  • 13.1 Impossible Foods
  • 13.2 Beyond Meat
  • 13.3 Eat Just, Inc.
  • 13.4 Upside Foods (formerly Memphis Meats)
  • 13.5 Mosa Meat
  • 13.6 Solar Foods
  • 13.7 Air Protein
  • 13.8 Ynsect
  • 13.9 Protix
  • 13.10 The EVERY Company (formerly Clara Foods)
  • 13.11 Perfect Day
  • 13.12 Nature's Fynd
  • 13.13 Meati Foods
  • 13.14 MycoTechnology, Inc.
  • 13.15 Shiok Meats
  • 13.16 Avant Meats
  • 13.17 Entomo Farms
  • 13.18 Ginkgo Bioworks

List of Tables

  • Table 1 Global Novel Food Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Novel Food Market Outlook, By Type (2023-2034) ($MN)
  • Table 3 Global Novel Food Market Outlook, By Plant-Based Alternatives (2023-2034) ($MN)
  • Table 4 Global Novel Food Market Outlook, By Insect-Based Food (2023-2034) ($MN)
  • Table 5 Global Novel Food Market Outlook, By Microbial & Algae-Based Food (2023-2034) ($MN)
  • Table 6 Global Novel Food Market Outlook, By Cultured & Lab-Grown Meat (2023-2034) ($MN)
  • Table 7 Global Novel Food Market Outlook, By Novel Plant Extracts (2023-2034) ($MN)
  • Table 8 Global Novel Food Market Outlook, By Source (2023-2034) ($MN)
  • Table 9 Global Novel Food Market Outlook, By Plant (2023-2034) ($MN)
  • Table 10 Global Novel Food Market Outlook, By Animal (2023-2034) ($MN)
  • Table 11 Global Novel Food Market Outlook, By Microbial (2023-2034) ($MN)
  • Table 12 Global Novel Food Market Outlook, By Fungi & Algae (2023-2034) ($MN)
  • Table 13 Global Novel Food Market Outlook, By Synthetic/Lab (2023-2034) ($MN)
  • Table 14 Global Novel Food Market Outlook, By Application (2023-2034) ($MN)
  • Table 15 Global Novel Food Market Outlook, By Dairy Alternatives (2023-2034) ($MN)
  • Table 16 Global Novel Food Market Outlook, By Meat Alternatives (2023-2034) ($MN)
  • Table 17 Global Novel Food Market Outlook, By Bakery & Confectionery (2023-2034) ($MN)
  • Table 18 Global Novel Food Market Outlook, By Beverages (2023-2034) ($MN)
  • Table 19 Global Novel Food Market Outlook, By Supplements & Nutraceuticals (2023-2034) ($MN)
  • Table 20 Global Novel Food Market Outlook, By Infant Formula (2023-2034) ($MN)
  • Table 21 Global Novel Food Market Outlook, By Form (2023-2034) ($MN)
  • Table 22 Global Novel Food Market Outlook, By Solid (2023-2034) ($MN)
  • Table 23 Global Novel Food Market Outlook, By Liquid (2023-2034) ($MN)
  • Table 24 Global Novel Food Market Outlook, By Powder (2023-2034) ($MN)
  • Table 25 Global Novel Food Market Outlook, By Gel (2023-2034) ($MN)
  • Table 26 Global Novel Food Market Outlook, By End User (2023-2034) ($MN)
  • Table 27 Global Novel Food Market Outlook, By Food & Beverage Manufacturers (2023-2034) ($MN)
  • Table 28 Global Novel Food Market Outlook, By Pharmaceutical Companies (2023-2034) ($MN)
  • Table 29 Global Novel Food Market Outlook, By Nutraceutical Companies (2023-2034) ($MN)
  • Table 30 Global Novel Food Market Outlook, By Animal Feed Industry (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.